Insider trade

Incyte (INCY): EVP & General Counsel sold ~$45K

Sheila A. Denton, EVP & General Counsel at Incyte, sold ~$45K of Incyte shares.

~$45K
Approx. value · 598 sh @ $75.77
33K
Holds after · shares reported
Traded
Aug 4, 2025
Filed
Aug 6, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 3, 2025InsiderOfficer sold ~$122K of INCY shares in the open market
  2. Jul 2, 2025InsiderOfficer sold ~$41K of INCY shares in the open market
  3. Jul 3, 2025Insider · 2 peopleInsiders: 3 sales (~$1.3M)
  4. Jul 14, 2025InsiderOfficer sold ~$1.02M of INCY shares in the open market
  5. Jul 15, 2025Insider · 3 peopleInsiders: 3 sales (~$398K)
  6. Jul 16, 2025Insider · 3 peopleInsiders: 3 sales (~$212K)
  7. Jul 21, 2025InsiderOfficer sold ~$252K of INCY shares in the open market
  8. Aug 4, 2025 · this disclosureInsiderOfficer sold ~$45K of INCY shares in the open market

What came next

  1. Aug 15, 2025InsiderOfficer sold ~$24K of INCY shares in the open market
  2. Sep 2, 2025InsiderOfficer sold ~$51K of INCY shares in the open market
  3. Sep 16, 2025InsiderOfficer sold ~$23K of INCY shares in the open market
  4. Sep 18, 2025FDAFDA drug approval: Opzelura
  5. Sep 30, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 30, 2025, the Board of Directors of Incyte Corporation (the “Company”) appointed Thomas Tray, the Company’s current Vice President, Finance and Chief Accounting Officer (principal accounting officer), to the additional position of principal financial officer, effective as of September 16, 2025.”
  6. Oct 2, 2025InsiderOfficer sold ~$53K of INCY shares in the open market
  7. Oct 3, 2025InsiderOfficer sold ~$299K of INCY shares in the open market
  8. Oct 15, 2025InsiderOfficer sold ~$24K of INCY shares in the open market
  9. Oct 17, 20255% stakeBlackRock, Inc. reported a passive stake (13G) of 7.8%
  10. Oct 28, 2025Company filing · Form 8-K · ResultsReported its results
  11. Nov 3, 2025InsiderOfficer sold ~$289K of INCY shares in the open market
  12. Nov 4, 2025InsiderOfficer sold ~$61K of INCY shares in the open market
  13. Nov 5, 2025InsiderOfficer sold ~$535K of INCY shares in the open market
  14. Nov 10, 20255% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.0%
  15. Nov 10, 2025Insider · Their largest sale since 2017Director sold ~$19.8M of INCY shares in the open market
  16. Nov 17, 2025InsiderOfficer sold ~$29K of INCY shares in the open market
  17. Nov 21, 2025InsiderOfficer sold ~$17K of INCY shares in the open market
  18. Nov 24, 2025InsiderOfficer sold ~$62K of INCY shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Incyte

For Incyte, OQRO holds 24 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INCY page.

Other recent filings by Sheila A. Denton, EVP & General Counsel

The full history of Sheila A. Denton, EVP & General Counsel is on the profile page.

How this filing works

Explore the data

Common questions

Which Incyte (INCY) insider traded, and how much?

Sheila A. Denton, EVP & General Counsel at Incyte, sold ~$45K of Incyte shares. 598 shares at $75.77.

When did it happen, and when was it made public?

Traded: Aug 4, 2025. Filed: Aug 6, 2025. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Incyte recently?

For Incyte, OQRO holds 24 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the INCY page.

Does this mean INCY stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Incyte

Everything OQRO holds on this company is on its INCY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data